NYSE:CVS

CVS Health Corp (CVS)

95.93
+1.11 (1.17%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
247 watching
0
TOP PICK
A very unique business model. There is some uncertainty over healthcare reform but the value is there. A defensive name which is important in this environment. (Analysts’ price target is $81.13)
BUY

Opportunities to lower cost structure of US healthcare are welcome. US healthcare is more expensive than elsewhere in the world. You're better to invest in a new concept that is under cover of an existing business, such as CVS. A pure play like TDOC is benefitting from Covid, and the stock price might wane when it's not such front page news.

TOP PICK
He is surprised they did not do better going into this crisis. They are big in the healthcare management area. Buying a company like this in the US at these valuations is a very prudent move and he expects it to do very well over the coming years. (Analysts’ price target is $79.74)
COMMENT

He has chosen to exit their holding about a year ago, based on their UK alliance (due to Brexit). He participates in the space with CVS instead, who bought a pharmacy benefits company. CVS has more than 10,000 locations in the US. The company has become vertically integrated, which gives them a long runway. Their "Health Hub" offers medical practitioners to people who would not otherwise have access to one.

PAST TOP PICK

(A Top Pick Apr 22/19, Up 25%) Undervalued at 9x PE, still likes it. This is the future of US healthcare where costs are 50% more than other western countries. A way to reduce this cost is through CVS, such as using their health hub technology instead of walking into emergency. CVS has been smart developing this business. CVS also gets a cheaper line of drugs and they recently bought Aetna. Altogether, CVS is vertically integrated. A great company.

PAST TOP PICK
(A Top Pick May 03/19, Up 12%) It held in there nicely. It set back to its book value after a good run. He would still buy it.
DON'T BUY

Healthcare is one of the best three sectors over the last 50 years. Eli Lily is a better choice. He's not in drugstores, because they are cyclical, such as 2008-9 when they got hit in a slow economy. Drugstores make their money buying impulse items in addition to their drugs, and people don't buy in tough times. He suggest Costco which fulfills prescriptions, but sells groceries. And Amazon is getting into this space.

HOLD
This has been hurt badly due to the virus. They had a good last quarter. She would continue to hold it. The risk of regulatory concern is lower too now that Biden looks like the likely Democrat candidate.
PARTIAL BUY

There are two positives there for them. They are a drug distributor and they are now into healthcare insurance. With Sanders looking less likely to be the Democrat candidate, they should see some benefit. He is concerned there is a lot of competition out there for this space, like Costco, Walmart and others. Near term he could see a bottom coming in the share price and will be looking to pick away at it.

WAIT
He had owned this a couple of years ago. He has favoured other health plays, but is watching this again. With Bernie Sanders rising in the Democratic leadership race, the threat to the pharma community is rising again. There is headline risk in this space. A share price drop of $5 might bring him in on this stock, but waiting is probably best.
TOP PICK
An integrated health company, including insurance. This business model lets them add value to customers. There's some uncertainty about US healthcare reform which has hit CVS's valuation of 9x earnings with a 9% free cash flow yield. Amazing value. (Analysts’ price target is $84.08)
TOP PICK
Becoming a full health-care services company. It's all about scale. Paid down debt. Trades at 10x, cheap right now. Dividend may not grow for next couple of years. Yield is 2.78%. (Analysts’ price target is $84.04)
BUY

The pharma retailers are becoming full-service, like Loblaw buying Shoppers Drug Mart. There's better growth in drugstore bricks and mortar retailing. Trades at a reasonable multiple. You're fine to hold this.

COMMENT
He likes this space. It's toppy now, with $80 as the top, a level it rarely breaks. Just be aware of that.
DON'T BUY
He does not hold this currently. It is in the middle of the pack in terms of valuation metrics, especially since it holds a higher level of debt.
Showing 136 to 150 of 409 entries